Bruce Thompson, Kincell Bio CEO

Ex­clu­sive: Cell ther­a­py CD­MO Kin­cell launch­es, and the spin­out is val­ued at $66M, with CEO look­ing for carve-outs

A small CD­MO called Kin­cell Bio launched Wednes­day, with its CEO hop­ing to fill a niche of­fer­ing cell ther­a­py man­u­fac­tur­ing for ear­ly-stage biotech star­tups.

Kin­cell is a spin­out of a Gainesville, FL-based man­u­fac­tur­ing plant of In­cep­tor Bio, a North Car­oli­na cell ther­a­py biotech found­ed in 2020. It’s raised $36 mil­lion in a Se­ries A fi­nanc­ing led by Ki­neti­cos Ven­tures, which val­ues the start­up at $66 mil­lion, a source fa­mil­iar with the mat­ter told End­points News.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.